-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Plenary Scientific Session

PhD Trainee
Program: General Sessions
Sunday, December 6, 2020: 7:00 AM-9:00 AM
Chair:
Stephanie J. Lee, MD, MPH, President, American Society of Hematology, Clinical Research Division, Fred Hutchinson Cancer Research Center
Disclosures:
Lee: AstraZeneca: Research Funding; Incyte: Consultancy, Research Funding; Amgen: Research Funding; Kadmon: Research Funding; Novartis: Research Funding; Pfizer: Consultancy, Research Funding; Syndax: Research Funding; Takeda: Research Funding.
During this highlight of the annual meeting, attendees will hear the presentations of the highest-caliber scientific abstracts selected by the Program Committee from among the thousands submitted from around the world.

Anthony R Green, PhD FRCPath FMedSci

University of Cambridge, Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom

Christian Marinaccio, MSc1*, Praveen K Suraneni, PhD1*, Hamza Celik, PhD2, Andrew Volk, PhD3, Jeremy Q. Wen, MD, PhD4*, Te Ling, PhD4*, Terra Lasho, PhD5, Richard P. Koche, PhD6*, Christopher Famulare, MS7*, Brady L. Stein, MD8, Sandeep Gurbuxani, MBBS, PhD9, Ronald Hoffman, MD10,11, Naseema Gangat, MBBS5, Navdeep Chandel12*, Ross L. Levine, MD13, Raajit K. Rampal, MD, PhD14, Grant Challen15, Ayalew Tefferi, MD5 and John D. Crispino, PhD16

1Division of Hematology/Oncology, Northwestern University, Chicago, IL
2Washington University in St Louis - School of Medicine, ST LOUIS, MO
3Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital, Cincinnati, OH
4Division of Experimental Hematology, St. Jude Children's Research Hospital, Memphis, TN
5Division of Hematology, Mayo Clinic, Rochester, MN
6Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York City, NY
7Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY
8Hematology/Oncology, Northwestern University, Chicago, IL
9Department of Pathology, University of Chicago, Chicago, IL
10Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
11MPN Research Consortium, New York, NY
12Northwestern University, Chicago, IL
13Memorial Sloan Kettering Cancer Center, New York, NY
14Leukemia Service, Department of Medicine, Clinical Director, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
15Washington University School of Medicine, St Louis, MO
16Experimental Hematology, St. Jude Children's Research Hospital, Memphis

Lisa Baumann Kreuziger, MD

Versiti, Milwaukee, WI

Terry B. Gernsheimer, MD1,2, Siobhan P Brown, PhD3*, Darrell J Triulzi, MD 4, Nigel S. Key, MD5, Nahed El Kassar, MD, PhD6*, Heather Herren, RN, MPH7* and Susanne May, PhD7*

1Department of Medicine, Division of Hematology, University of Washington School of Medicine, Seattle, WA
2Seattle Cancer Care Alliance, Seattle, WA
3Biostatistics Department, University of Washington School of Public Health, Seattle, WA
4Division of Transfusion Medicine, Institute for Transfusion Medicine, Pittsburgh, PA
5Division of Hematology/Oncology, University of North Carolina Hospitals, Chapel Hill, NC
6National Heart Lung and Blood Institute (NHLBI), National Institute of Health, Bethesda, MD
7Department of Biostatistics, University of Washington, Seattle, WA

Laura Pasqualucci, MD

Columbia University, New York, NY

Min Xia1, Liron David, PhD2*, Matthew Teater, PhD3*, Ozlem Onder, PhD, MSc4*, Kojo S. J. Elenitoba-Johnson, MD5, Lorena Fontan, PhD6, Hao Wu, PhD2* and Ari Melnick, MD1

1Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY
2Program in Cellular and Molecular Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA
3Medicine, Weill Cornell Medicine, New York, NY
4Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
5Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
6Division of Hematology/Oncology, Department of Medicine, Weill Cornell Medicine, Long Island City, NY

Alexis A. Thompson, MD

Northwestern University, Chicago, IL

Haydar Frangoul, MD1*, Yael Bobruff, PhD2*, Maria Domenica Cappellini3, Selim Corbacioglu, MD4, Christine Marie Fernandez, RN, MSN2*, Josu de la Fuente5, Stephan A Grupp, MD, PhD6, Rupert Handgretinger, MD7, Tony W. Ho, MD2*, Suzan Imren, MD8*, Antonis Kattamis9, Julie Lekstrom-Himes, MD8*, Franco Locatelli, MD, PhD10, Yimeng Lu, PhD8*, Markus Y Mapara, MD, PhD11, Mariane de Montalembert, MD, PhD12*, Sarah D. Mulcahey, MS8*, Damiano Rondelli, MD13, Niraj Shanbhag, MD, PhD8*, Sujit Sheth, MD14, Sandeep Soni, MBBS2*, Martin H. Steinberg, MD15, Michael J. Weinstein2*, John K. Wu, MBBS, FRCPC, MS16 and Donna Wall, MD, CCPE17

1Tristar Children's Hospital, Nashville, TN
2CRISPR Therapeutics, Cambridge, MA
3Foundation IRCCS Ca' Granda Policlinico Milano - University of Milan, Milano, MI, Italy
4Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University of Regensburg, Regensburg, Germany
5Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
6Children's Hospital of Philadelphia, Philadelphia, PA
7Department of Hematology and Oncology, University Children's Hospital Tuebingen, Tuebingen, Germany
8Vertex Pharmaceuticals Incorporated, Boston, MA
9Pediatric Hematology Oncology Unit, First Department of Pediatrics, National and Kapodistrian University of Athens, Aghia Sophia Children’s Hospital, Athens, Greece
10Department of Pediatric Hematology/Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy
11Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY
12Hôpital Universitaire Necker-Enfants Malades, Paris, France
13Division of Hematology/Oncology, University of Illinois, Chicago, IL
14Division of Pediatric Hematology/Oncology, Weill Cornell Medicine, New York, NY
15Department of Medicine, Section of Hematology-Medical Oncology, Boston University School of Medicine, Boston, MA
16Division of Hematology/Oncology, UBC & B.C. Children's Hospital, Vancouver, BC, Canada
17Hospital for Sick Kids, Toronto, Canada

Ravi Majeti

Department of Medicine, Division of Hematology, Cancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA

Kerstin B Kaufmann, PhD1, Andy G.X. Zeng, BSc2, Etienne Coyaud3*, Laura Garcia Prat, PhD, BSc, MSc3, Efthymia Papalexi, BA4,5*, Estelle MN Laurent3*, Michelle Chan-Seng-Yue1,6*, Olga I. Gan, PhD1*, Kristele Pan1*, Jessica L. McLeod1*, Sasan Zandi3,7*, Shin-Ichiro Takayanagi, PhD8,9*, Rahul Satija4,5*, Brian Raught3*, Stephanie Zhi-Juan Xie, PhD1 and John E. Dick, PhD, FRS1

1Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, ON, Canada
2Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
3Princess Margaret Cancer Centre; University Health Network, Toronto, Canada
4New York Genome Center, New York, NY
5Center for Genomics and Systems Biology, New York University, New York
6PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Canada
7Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada
8Cell Therapy Project; R&D Division, Kirin Holdings Company, Limited, Tokyo, Japan
9Princess Margaret Cancer Centre, University Health Network (UHN), Toronto, Canada

Chancellor E Donald, MD

Section of Hematology/Medical Oncology, Tulane University School of Medicine, New Orleans, LA

Bhavana Bhatnagar, DO1, Qiuhong Zhao, MS2,3*, James L. Fisher, PhD4*, Jessica Kohlschmidt, PhD5, Krzysztof Mrózek, MD, PhD5, Deedra Nicolet, MS5*, Shelley Orwick, BS6*, James S. Blachly, MD5,7, Alice S. Mims, MD5, Christopher J. Walker, PhD8, Andrew J Carroll, PhD9, Bayard L. Powell, MD10, Jonathan E. Kolitz, MD11, Electra D. Paskett, PhD12*, Clara D. Bloomfield, MD2, Richard M. Stone, MD13, John C. Byrd, MD6, Albert de la Chapelle, MD, PhD8*, Ramiro Garzon, MD5 and Ann-Kathrin Eisfeld, MD6

1Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
2Comprehensive Cancer Center, The Ohio State University, Columbus, OH
3Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
4The Ohio State University, Columbus, OH
5The Ohio State University Comprehensive Cancer Center, Columbus, OH
6Division of Hematology, The Ohio State University, Columbus, OH
7Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH
8The Ohio State University, Comprehensive Cancer Center, Columbus, OH
9Department of Genetics, University of Alabama at Birmingham, Birmingham, AL
10Wake Forest Univ. School of Med., Winston Salem, NC
11Northwell Health Cancer Institute, Zucker School of Medicine at Hofstra/Northwell, Lake Success, NY
12The Ohio State University, Columbus
13Department of Medical Oncology, Dana-Farber Cancer Institute, Boston

See more of: General Sessions